— Know what they know.
Not Investment Advice

CTKB NASDAQ

Cytek Biosciences, Inc.
1W: +17.9% 1M: -14.8% 3M: -10.6% YTD: -19.5% 1Y: +48.9% 3Y: -42.5%
$4.01
+0.05 (+1.26%)
 
Weekly Expected Move ±10.3%
$3 $3 $3 $4 $4
NASDAQ · Healthcare · Medical - Devices · Alpha Radar Strong Sell · Power 27 · $517.9M mcap · 118M float · 0.671% daily turnover · Short 57% of daily vol

Edge Score

Quantitative competitive moat analysis scoring five pillars of durable advantage — cost leadership, brand intangibles, switching costs, network effects, and efficient scale — using industry percentile rankings on a 0–100 scale.

NO EDGE
36.6 / 100
NoneWeakNarrowWide
Primary source: Switching Costs  ·  ROIC: -30.6%  ·  5Y Avg: -9.4%
Cost Advantage
38
Intangibles
33
Switching Cost
39
Network Effect
38
Scale
35
The Edge Score quantifies a company's competitive moat using five pillars: Cost Advantage (20%, operating margin and SG&A efficiency vs industry peers), Intangible Assets (25%, gross margin premium, R&D intensity, brand pricing power), Switching Costs (25%, revenue stability, earnings consistency, customer retention proxied by operating leverage), Network Effects (15%, revenue growth with expanding margins, market share dominance), and Efficient Scale (15%, market concentration, ROIC sustainability). Each pillar is scored 0–100 using industry percentile rankings, then weighted into a composite. Wide ≥ 70, Narrow ≥ 55, Weak ≥ 40, None < 40. CTKB has No discernible competitive edge (36.6/100). The business operates without significant structural advantages. The primary source of advantage is Switching Costs. Negative ROIC of -30.6% indicates the company is currently destroying value, though this may reflect a growth investment phase.

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets
$5
Low
$5
Avg Target
$6
High
Based on 2 analysts since May 7, 2026 earnings
Analyst Recommendations
Strong Buy: 0Buy: 3Hold: 1Sell: 1Strong Sell: 0
Rating Summary
ConsensusBuy
Avg Target$5.13
Analysts2
Price Target Change History
DateFirmAnalystOldNewChangeUpside @ CallStock@Call
2026-05-13 Stephens Initiated $5 +17.6% $4.04
2026-05-12 Morgan Stanley $6 $6 -0 +35.3% $4.07
2025-12-01 Morgan Stanley Initiated $6 +12.6% $5.33
2025-03-04 Piper Sandler $8 $8 -0 +85.6% $4.31
2025-02-02 Goldman Sachs Matthew Sykes Initiated $5 +1.9% $5.15
2024-05-13 Piper Sandler Dave Westenberg $16 $8 -8 +38.2% $6.15
2022-08-17 Piper Sandler David Westenberg $12 $16 +4 +13.6% $14.08
2022-05-15 Piper Sandler David Westenberg Initiated $12 +27.9% $9.38

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

C+
May 22, 2026
DCF
3
ROE
1
ROA
1
D/E
3
P/E
1
P/B
3
The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. CTKB receives an overall rating of C+. Areas of concern: ROE (1/5), ROA (1/5), P/E (1/5).
Rating Change History
DateFromTo
2026-05-14 C C+
2026-05-11 C+ C
2026-05-08 C C+
2026-04-01 C+ C
2026-01-13 B- C+
2026-01-03 C+ B-

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

31 Grade D
Profitability
14
Balance Sheet
44
Earnings Quality
30
Growth
35
Value
40
Momentum
37
Safety
90
Cash Flow
20
The InsiderStreet Scorecard rates companies across eight dimensions: Profitability (margins, ROA, ROE), Balance Sheet (leverage, liquidity, coverage), Earnings Quality (accruals, cash conversion), Growth (revenue and earnings trajectory), Value (P/E, P/B, earnings yield, Graham criteria), Momentum (revenue and earnings acceleration), Safety (Altman Z-Score risk adjustment), and Cash Flow (operating cash flow quality, FCF conversion, cash coverage). The overall score blends 35% quality, 35% value, and 30% momentum, with a penalty for distress-zone Altman scores. CTKB scores highest in Safety (90/100) and lowest in Profitability (14/100). A grade of D flags significant fundamental concerns across multiple dimensions.

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
3.51
Safe Zone
Piotroski F-Score
2/9
Beneish M-Score
-3.20
Unlikely Manipulator
Ohlson O-Score
-7.67
Bankruptcy prob: 0.0%
Low Risk
Credit Rating
BBB+
Score: 60.7/100
Trend: Deteriorating
Earnings Quality
OCF/NI: 0.10x
Accruals: -13.9%
The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. CTKB scores 3.51, placing it in the Safe Zone (safe > 2.99, distress < 1.81). Bankruptcy is statistically unlikely within the next two years. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. CTKB scores 2/9, suggesting weak financial fundamentals — the company fails the majority of these accounting tests. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. CTKB's score of -3.20 falls below this threshold, suggesting earnings are unlikely to be manipulated. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. CTKB's implied 0.0% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. CTKB receives an estimated rating of BBB+ (score: 60.7/100), with a deteriorating trend.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
-6.97x
PEG
0.05x
P/S
2.54x
P/B
1.58x
P/FCF
-44.29x
P/OCF
EV/EBITDA
-14.21x
EV/Revenue
1.64x
EV/EBIT
-9.43x
EV/FCF
-26.30x
Earnings Yield
-13.16%
FCF Yield
-2.26%
Shareholder Yield
0.79%
Graham Number
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. CTKB currently has negative earnings — the P/E ratio is not meaningful.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
2.059
NI / EBT
×
Interest Burden
1.015
EBT / EBIT
×
EBIT Margin
-0.173
EBIT / Rev
×
Asset Turnover
0.425
Rev / Assets
×
Equity Multiplier
1.303
Assets / Equity
=
ROE
-20.1%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. CTKB's ROE of -20.1% is driven by Asset Turnover (0.425), indicating efficient use of assets to generate revenue. A tax burden ratio of 2.06 indicates minimal tax leakage — the company retains over 90% of pre-tax earnings.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Adj. Growth Rate
0.00%
Fair P/E
8.50x
Intrinsic Value
Price/Value
Margin of Safety
Premium
Assessment
Overvalued

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1214 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$4.01
Median 1Y
$2.35
5th Pctile
$0.87
95th Pctile
$6.45
Ann. Volatility
65.6%
Analyst Target
$5.13
25th–75th percentile 5th–95th percentile Median path Historical Analyst target

Executive Compensation

C-suite compensation breakdown including salary, stock awards, options, and incentive pay. The CEO-to-employee pay ratio and Gini coefficient measure pay distribution fairness.

C-Suite Compensation

ExecutiveSalaryStockTotal
Wenbin Jiang, Ph.D.
Chief Executive Officer and President
$620,000 $2,000,000 $5,120,061
William McCombe Financial
ancial Officer
$450,000 $900,000 $2,460,979
Valerie Barnett Legal
Legal Officer and Corporate Secretary
$475,000 $750,000 $2,174,943
Ming Yan, Ph.D.
Chief Technology Officer
$425,000 $425,000 $1,457,420
Philippe Busque, Ph.D.
Senior Vice President, Global Sales and Services
$375,000 $250,000 $1,021,730

CEO Pay Ratio

33:1
CEO-to-Employee Pay Ratio
CEO Total Comp: $5,120,061
Avg Employee Cost (SGA/emp): $154,382
Employees: 702

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees
702
+8.3% YoY
Revenue / Employee
$287,027
Rev: $201,493,000
Profit / Employee
$-94,785
NI: $-66,539,000
SGA / Employee
$154,382
Avg labor cost proxy
R&D / Employee
$51,949
Innovation spend

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
ROE -8.9% 0.1% -0.4% -0.6% -1.1% 0.6% -0.5% -1.4% -3.4% -3.0% -2.8% -4.3% -2.5% -1.5% -2.9% -1.6% -3.3% -18.0% -20.1% -20.07%
ROA 0.6% 0.0% -0.4% -0.5% -0.6% 0.5% -0.4% -1.2% -2.9% -2.4% -2.3% -3.5% -2.0% -1.2% -2.3% -1.3% -2.6% -13.8% -15.4% -15.40%
ROIC -1.1% 1.1% 3.6% 1.9% -1.1% -3.5% -9.0% -15.3% -21.3% -15.2% -14.4% -14.1% -12.9% -12.0% -14.5% -15.7% -18.6% -28.2% -30.6% -30.61%
ROCE 1.3% 0.8% 0.2% -0.0% -0.0% 0.8% -0.4% -1.5% -2.8% -3.1% -3.2% -3.4% -2.5% -4.8% -5.3% -5.2% -6.9% -7.3% -9.2% -9.23%
Gross Margin 61.9% 60.8% 57.5% 61.2% 66.4% 60.8% 56.7% 56.7% 56.6% 56.8% 51.3% 54.6% 56.3% 58.5% 48.6% 52.3% 52.7% 52.9% 48.2% 48.16%
Operating Margin 8.4% 3.4% -6.7% -2.2% 3.4% 0.2% -32.8% -18.4% -13.4% -0.2% -23.9% -18.3% -8.2% 5.2% -36.1% -23.3% -17.6% -9.0% -41.8% -41.83%
Net Margin 4.1% -3.1% -5.8% -1.5% 4.1% 7.3% -18.4% -8.8% -13.5% 9.4% -13.8% -22.4% 1.8% 16.8% -27.5% -12.2% -10.5% -70.9% -42.7% -42.75%
EBITDA Margin 7.9% 4.2% -3.5% 0.3% 8.1% 13.8% -19.9% -9.2% -2.1% 11.9% -13.6% -9.8% 6.0% -4.3% -19.5% -7.4% -8.1% -0.4% -35.5% -35.46%
FCF Margin -0.4% 5.5% 1.6% -6.1% -11.3% -13.4% -10.5% -6.2% -4.3% 0.2% 0.7% 5.4% 14.3% 10.9% 8.9% 5.6% -3.0% -4.4% -6.2% -6.22%
OCF Margin 3.4% 9.0% 4.7% -2.9% -8.4% -7.5% -4.8% -0.7% 1.1% 2.7% 3.2% 7.8% 16.3% 12.7% 10.8% 7.8% -1.0% -2.3% -3.6% -3.57%
ROE 3Y Avg snapshot only -9.14%
ROE 5Y Avg snapshot only -5.68%
ROA 3Y Avg snapshot only -6.87%
ROIC 3Y Avg snapshot only -14.00%
ROIC Economic snapshot only -9.35%
Cash ROA snapshot only -1.58%
Cash ROIC snapshot only -6.44%
CROIC snapshot only -11.21%
NOPAT Margin snapshot only -16.98%
Pretax Margin snapshot only -17.61%
R&D / Revenue snapshot only 17.80%
SGA / Revenue snapshot only 55.39%
SBC / Revenue snapshot only 11.17%
Valuation
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
P/E Ratio 1713.36 8098.52 -805.51 -603.41 -952.33 543.10 -563.41 -193.46 -53.23 -98.13 -76.32 -41.78 -72.41 -139.32 -45.74 -67.42 -34.52 -9.73 -7.60 -6.974
P/S Ratio 70.78 25.31 13.32 9.71 13.21 8.53 7.50 6.61 4.10 6.18 4.38 3.71 3.66 4.18 2.61 2.20 2.25 3.21 2.75 2.536
P/B Ratio -151.80 4.58 3.56 3.56 5.04 3.29 2.93 2.73 1.77 3.03 2.23 1.87 1.87 2.12 1.30 1.09 1.12 1.89 1.65 1.575
P/FCF -16550.86 463.06 827.20 -159.83 -116.74 -63.42 -71.37 -106.53 -94.98 2625.81 611.75 68.82 25.63 38.39 29.35 39.01 -74.96 -73.80 -44.29 -44.294
P/OCF 2095.59 280.61 281.43 383.12 225.74 137.69 47.52 22.36 33.04 24.16 28.39
EV/EBITDA 839.38 344.42 349.94 337.25 446.06 122.21 343.94 -419.47 -68.06 -156.45 -132.42 -101.82 -750.94 -57.59 -21.10 -15.76 -10.02 -26.27 -14.21 -14.209
EV/Revenue 66.05 20.33 9.96 7.26 10.85 6.56 5.55 4.77 2.34 4.89 3.14 2.45 2.42 2.88 1.29 0.87 0.92 2.08 1.64 1.636
EV/EBIT 902.43 431.62 1459.88 -71835.12 -52411.98 280.71 -506.37 -115.50 -32.13 -69.21 -45.59 -33.03 -45.03 -28.15 -11.06 -7.67 -6.10 -15.00 -9.43 -9.432
EV/FCF -15445.70 372.02 618.25 -119.42 -95.89 -48.78 -52.85 -76.88 -54.16 2078.96 438.86 45.53 16.98 26.45 14.47 15.43 -30.78 -47.75 -26.30 -26.298
Earnings Yield 0.1% 0.0% -0.1% -0.2% -0.1% 0.2% -0.2% -0.5% -1.9% -1.0% -1.3% -2.4% -1.4% -0.7% -2.2% -1.5% -2.9% -10.3% -13.2% -13.16%
FCF Yield -0.0% 0.2% 0.1% -0.6% -0.9% -1.6% -1.4% -0.9% -1.1% 0.0% 0.2% 1.5% 3.9% 2.6% 3.4% 2.6% -1.3% -1.4% -2.3% -2.26%
PEG Ratio snapshot only 0.047
Price/Tangible Book snapshot only 1.825
EV/Gross Profit snapshot only 3.164
Shareholder Yield snapshot only 0.79%
Leverage & Solvency
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Current Ratio 7.86 13.01 13.01 13.01 13.01 9.26 9.26 9.26 9.26 6.97 6.97 6.97 6.97 5.86 5.86 5.86 5.86 5.04 5.04 5.038
Quick Ratio 6.99 12.04 12.04 12.04 12.04 8.28 8.28 8.28 8.28 5.89 5.89 5.89 5.89 5.21 5.21 5.21 5.21 4.42 4.42 4.416
Debt/Equity -0.17 0.00 0.00 0.00 0.00 0.04 0.04 0.04 0.04 0.04 0.04 0.04 0.04 0.04 0.04 0.04 0.04 0.10 0.10 0.097
Net Debt/Equity -0.90 -0.90 -0.90 -0.90 -0.76 -0.76 -0.76 -0.76 -0.63 -0.63 -0.63 -0.63 -0.66 -0.66 -0.66 -0.66 -0.67 -0.67 -0.669
Debt/Assets 0.01 0.00 0.00 0.00 0.00 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.07 0.07 0.072
Debt/EBITDA 1.02 0.00 0.00 0.00 0.00 2.06 6.75 -9.06 -2.87 -2.34 -2.97 -2.97 -21.78 -1.70 -1.41 -1.57 -0.94 -2.07 -1.41 -1.405
Net Debt/EBITDA -60.06 -84.29 -118.27 -114.12 -96.97 -36.69 -120.50 161.77 51.29 41.15 52.17 52.10 382.55 26.00 21.68 24.08 14.39 14.33 9.72 9.723
Interest Coverage 5.71 3.70 0.49 -0.01 -0.01 1.49 -0.69 -3.00 -5.64 -6.59 -7.52 -9.39 -9.95 -29.57 -42.18 -27.01 -24.86 -14.51 -18.68 -18.683
Equity Multiplier -13.72 1.14 1.14 1.14 1.14 1.22 1.22 1.22 1.22 1.26 1.26 1.26 1.26 1.26 1.26 1.26 1.26 1.35 1.35 1.351
Cash Ratio snapshot only 3.361
Debt Service Coverage snapshot only -12.402
Cash to Debt snapshot only 7.919
FCF to Debt snapshot only -0.385
Defensive Interval snapshot only 815.0 days
Efficiency & Turnover
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Asset Turnover 0.16 0.16 0.23 0.32 0.45 0.33 0.34 0.36 0.37 0.38 0.40 0.39 0.40 0.40 0.40 0.39 0.40 0.42 0.42 0.425
Inventory Turnover 0.57 0.88 1.34 1.83 2.15 1.57 1.60 1.75 1.93 1.53 1.64 1.63 1.66 1.71 1.70 1.71 1.75 2.10 2.14 2.136
Receivables Turnover 2.02 2.46 3.64 4.99 6.61 4.17 4.22 4.47 4.66 3.68 3.83 3.77 3.84 3.44 3.38 3.36 3.38 3.27 3.32 3.317
Payables Turnover 4.45 9.35 14.25 19.39 19.86 16.09 16.39 17.90 19.74 21.33 22.81 22.72 23.15 20.87 20.75 20.87 21.40 16.25 16.52 16.520
DSO 180 148 100 73 55 87 86 82 78 99 95 97 95 106 108 108 108 111 110 110.0 days
DIO 641 414 272 200 170 232 228 209 189 238 223 223 219 214 215 214 209 174 171 170.9 days
DPO 82 39 26 19 18 23 22 20 18 17 16 16 16 17 18 17 17 22 22 22.1 days
Cash Conversion Cycle 740 523 346 254 206 297 292 270 249 320 302 304 299 303 306 305 300 263 259 258.8 days
Fixed Asset Turnover snapshot only 6.963
Operating Cycle snapshot only 280.9 days
Cash Velocity snapshot only 0.781
Capital Intensity snapshot only 2.261
Growth (YoY)
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue 3.5% 1.2% 53.3% 18.3% 18.5% 17.7% 20.9% 12.6% 9.9% 3.9% -1.9% -0.8% -2.2% 0.5% 3.6% 3.61%
Net Income -2.5% 10.2% -23.3% -1.5% -5.6% -5.7% -4.2% -1.9% 28.1% 50.5% 2.2% 63.5% -26.2% -10.1% -5.6% -5.58%
EPS -2.2% 8.3% -21.9% -1.5% -5.7% -5.9% -4.4% -2.0% 26.2% 49.9% 0.3% 62.2% -31.4% -10.1% -5.6% -5.56%
FCF -118.0% -6.5% -11.0% -20.8% 54.8% 1.0% 1.1% 2.0% 4.6% 47.1% 11.2% 3.8% -1.2% -1.4% -1.7% -1.72%
EBITDA 39.0% 1.0% -13.0% -1.6% -2.7% -1.7% -2.8% -1.4% 89.7% -66.3% -1.5% -1.3% -26.9% -58.9% -95.3% -95.34%
Op. Income -1.2% -1.4% -7.3% -21.5% -47.4% -14.4% -1.3% -30.1% 14.4% 26.3% 6.3% -4.0% -34.5% -96.8% -77.2% -77.16%
OCF Growth snapshot only -1.34%
Asset Growth snapshot only -7.60%
Equity Growth snapshot only -13.64%
Debt Growth snapshot only 94.08%
Shares Change snapshot only 0.29%
Growth (CAGR)
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue 3Y 80.2% 39.9% 22.1% 9.7% 8.4% 7.1% 7.1% 7.13%
Revenue 5Y
EPS 3Y
EPS 5Y
Net Income 3Y
Net Income 5Y
EBITDA 3Y
EBITDA 5Y
Gross Profit 3Y 73.2% 35.2% 18.5% 6.0% 3.4% 1.1% 1.2% 1.20%
Gross Profit 5Y
Op. Income 3Y
Op. Income 5Y
FCF 3Y 76.0% 1.2%
FCF 5Y
OCF 3Y 2.0% 56.6% 60.7%
OCF 5Y
Assets 3Y 31.0% 2.5% 2.5% 2.5% 2.5% -3.9% -3.9% -3.86%
Assets 5Y
Equity 3Y -0.8% -0.8% -0.8% -0.8% -7.0% -7.0% -7.03%
Book Value 3Y -4.9% 0.6% 1.1% 2.0% -4.9% -5.4% -5.43%
Dividend 3Y
Growth Quality
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue Stability 0.89 0.92 0.98 1.00 0.83 0.82 0.83 0.86 0.79 0.78 0.66 0.662
Earnings Stability 0.91 0.61 0.78 0.92 0.71 0.43 0.81 0.22 0.71 0.62 0.63 0.634
Margin Stability 0.96 0.95 0.95 0.95 0.94 0.95 0.94 0.94 0.94 0.93 0.93 0.928
Rev. Growth Consistency 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 1.00 1.00 1.00 1.00 1.00 1.00 0.00 0.00 0.00 1.00 0.50 0.500
Earn. Growth Consistency 0.00 0.00 0.00 0.00 0.00 0.50 0.00 0.00 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 0.00 0.00 0.00 0.000
FCF Positive Streak 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 1 0 0 0 0
Earnings Persistence 0.50 0.20 0.50 0.50 0.89 0.50 0.99 0.50 0.90 0.50 0.50 0.500
Earnings Smoothness 0.00
ROE Trend -0.03 -0.02 -0.03 -0.01 -0.00 -0.01 0.01 -0.00 -0.17 -0.19 -0.188
Gross Margin Trend -0.04 -0.05 -0.05 -0.05 -0.05 -0.04 -0.03 -0.03 -0.03 -0.04 -0.04 -0.035
FCF Margin Trend 0.02 0.04 0.05 0.12 0.22 0.18 0.14 0.06 -0.08 -0.10 -0.11 -0.110
Sustainable Growth Rate 0.1% 0.6%
Internal Growth Rate 0.6% 0.0% 0.5%
Cash Flow Quality
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
OCF/Net Income 0.82 28.86 -2.86 1.80 6.05 -4.75 3.57 0.22 -0.14 -0.43 -0.55 -0.88 -3.24 -4.22 -1.89 -2.37 0.15 0.07 0.10 0.099
FCF/OCF -0.13 0.61 0.34 2.09 1.35 1.80 2.21 8.36 -4.03 0.09 0.23 0.69 0.87 0.86 0.82 0.73 3.08 1.87 1.74 1.740
FCF/Net Income snapshot only 0.172
CapEx/Revenue 3.8% 3.6% 3.1% 3.2% 2.9% 6.0% 5.8% 5.5% 5.4% 2.5% 2.5% 2.4% 2.1% 1.8% 1.9% 2.1% 2.0% 2.0% 2.6% 2.65%
CapEx/Depreciation snapshot only 0.454
Accruals Ratio 0.00 -0.01 -0.01 0.00 0.03 0.03 0.01 -0.01 -0.03 -0.03 -0.04 -0.07 -0.08 -0.06 -0.07 -0.04 -0.02 -0.13 -0.14 -0.139
Sloan Accruals snapshot only -0.055
Cash Flow Adequacy snapshot only -1.351
Dividends & Buybacks
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Dividend Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Dividend/Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Payout Ratio 0.0% 0.0% 0.0%
FCF Payout Ratio 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
Total Payout Ratio 0.0% 0.0% 2.8%
Div. Increase Streak
Chowder Number
Buyback Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 1.1% 3.6% 4.9% 6.3% 6.7% 2.6% 6.3% 7.9% 5.0% 2.3% 0.8% 0.79%
Net Buyback Yield -8.9% -11.7% -15.0% -15.1% -0.0% -0.1% -0.1% -0.1% 1.0% 3.6% 4.9% 6.3% 6.7% 2.6% 6.3% 7.7% 4.8% 2.1% 0.6% 0.56%
Total Shareholder Return -8.9% -11.7% -15.0% -15.1% -0.0% -0.1% -0.1% -0.1% 1.0% 3.6% 4.9% 6.3% 6.7% 2.6% 6.3% 7.7% 4.8% 2.1% 0.6% 0.56%
DuPont Factors
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Tax Burden (NI/EBT) 0.68 0.09 2.29 1.09 0.89 2.04 0.49 0.62 0.90 0.77 0.73 1.08 0.85 1.06 1.41 0.85 0.83 2.23 2.06 2.059
Interest Burden (EBT/EBIT) 0.82 0.73 -1.06 145.67 75.31 0.33 2.46 1.33 1.18 1.15 1.13 1.11 1.10 0.28 0.35 0.34 0.52 1.07 1.02 1.015
EBIT Margin 0.07 0.05 0.01 -0.00 -0.00 0.02 -0.01 -0.04 -0.07 -0.07 -0.07 -0.07 -0.05 -0.10 -0.12 -0.11 -0.15 -0.14 -0.17 -0.173
Asset Turnover 0.16 0.16 0.23 0.32 0.45 0.33 0.34 0.36 0.37 0.38 0.40 0.39 0.40 0.40 0.40 0.39 0.40 0.42 0.42 0.425
Equity Multiplier -13.72 1.14 1.14 1.14 1.76 1.18 1.18 1.18 1.18 1.24 1.24 1.24 1.24 1.26 1.26 1.26 1.26 1.30 1.30 1.303
Per Share
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
EPS (Diluted TTM) $0.01 $0.00 $-0.01 $-0.02 $-0.02 $0.02 $-0.02 $-0.04 $-0.10 $-0.09 $-0.09 $-0.13 $-0.08 $-0.05 $-0.09 $-0.05 $-0.10 $-0.52 $-0.57 $-0.57
Book Value/Share $-0.14 $3.56 $3.02 $3.01 $2.92 $3.10 $3.14 $3.13 $3.12 $3.01 $3.00 $2.99 $2.96 $3.06 $3.08 $3.12 $3.10 $2.67 $2.66 $2.55
Tangible Book/Share $-0.15 $3.43 $2.91 $2.90 $2.81 $3.00 $3.03 $3.02 $3.02 $2.71 $2.70 $2.69 $2.66 $2.78 $2.80 $2.83 $2.81 $2.40 $2.39 $2.39
Revenue/Share $0.30 $0.64 $0.81 $1.10 $1.11 $1.20 $1.23 $1.29 $1.34 $1.48 $1.53 $1.50 $1.52 $1.55 $1.54 $1.54 $1.54 $1.57 $1.59 $1.59
FCF/Share $-0.00 $0.04 $0.01 $-0.07 $-0.13 $-0.16 $-0.13 $-0.08 $-0.06 $0.00 $0.01 $0.08 $0.22 $0.17 $0.14 $0.09 $-0.05 $-0.07 $-0.10 $-0.10
OCF/Share $0.01 $0.06 $0.04 $-0.03 $-0.09 $-0.09 $-0.06 $-0.01 $0.01 $0.04 $0.05 $0.12 $0.25 $0.20 $0.17 $0.12 $-0.02 $-0.04 $-0.06 $-0.06
Cash/Share $1.45 $3.21 $2.72 $2.71 $2.63 $2.49 $2.52 $2.51 $2.51 $2.01 $2.00 $2.00 $1.98 $2.15 $2.17 $2.19 $2.18 $2.04 $2.03 $2.04
EBITDA/Share $0.02 $0.04 $0.02 $0.02 $0.03 $0.06 $0.02 $-0.01 $-0.05 $-0.05 $-0.04 $-0.04 $-0.00 $-0.08 $-0.09 $-0.09 $-0.14 $-0.12 $-0.18 $-0.18
Debt/Share $0.02 $0.00 $0.00 $0.00 $0.00 $0.13 $0.13 $0.13 $0.13 $0.11 $0.11 $0.11 $0.11 $0.13 $0.13 $0.13 $0.13 $0.26 $0.26 $0.26
Net Debt/Share $-1.43 $-3.21 $-2.72 $-2.71 $-2.63 $-2.36 $-2.38 $-2.38 $-2.37 $-1.90 $-1.90 $-1.89 $-1.87 $-2.02 $-2.03 $-2.05 $-2.05 $-1.78 $-1.78 $-1.78
Academic Models
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Altman Z-Score 3.514
Altman Z-Prime snapshot only 8.161
Piotroski F-Score 3 4 3 1 3 5 2 3 5 4 4 4 5 7 5 5 3 3 2 2
Beneish M-Score -1.61 -1.62 -1.72 -1.78 -1.82 -2.09 -2.06 -2.27 -2.39 -2.70 -2.69 -2.59 -2.49 -3.13 -3.20 -3.200
Ohlson O-Score snapshot only -7.673
ROIC (Greenblatt) snapshot only -10.31%
Net-Net WC snapshot only $2.11
EVA snapshot only $-45983070.00
Credit
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Credit Rating snapshot only BBB+
Credit Score 20.00 81.78 70.53 68.65 68.55 68.37 54.52 63.87 65.83 68.38 70.16 71.72 71.02 71.31 68.22 65.82 57.42 61.08 60.71 60.709
Credit Grade snapshot only 8
Credit Trend snapshot only -7.510
Implied Spread (bps) snapshot only 225.000
Industry Credit Rank snapshot only 56
Sector Credit Rank snapshot only 53

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms